Login / Signup

Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.

Jesse J FrykDenese C MarksJody Hobson-PetersDaniel WattersonRoy A HallPaul R YoungStefan ReichenbergFrank TolksdorfChryslain SumianUte GravemannAxel SeltsamHelen M Faddy
Published in: Transfusion (2017)
Our study demonstrates that the THERAFLEX UV-Platelets system and THERAFLEX MB-Plasma system can reduce ZIKV infectivity in PCs and pooled plasma to the detection limit of the assays used. These findings suggest both systems have the capacity to be an effective option to manage potential ZIKV transfusion transmission risk.
Keyphrases
  • zika virus
  • dengue virus
  • visible light
  • aedes aegypti
  • cardiac surgery
  • clinical trial
  • human health
  • phase iii
  • double blind